西藏天路(600326.SH)擬向高爭投資轉讓一宗土地使用權及地上建築物
格隆匯3月31日丨西藏天路(600326.SH)公佈,為全面落實西藏自治區關於國有企業整合重組和產業佈局的安排,剝離與主業無關的資產,公司擬將其持有的位於拉薩市柳梧新區的一處土地使用權及地上建築物轉讓至西藏高爭投資有限公司(以下簡稱“高爭投資”),轉讓價格為1.92億元(含税),最終交易金額將以經國資監管部門備案的評估值為基礎確定。
公司本次將持有的該處土地使用權及地上建築物以非公開協議轉讓方式出售至高爭投資,有利於全面落實西藏自治區關於國有企業整合重組和產業佈局的安排,集中資源聚焦建築建材等主營業務的發展,提高資產運營效率,增強資產的流動性,減少因折舊攤銷及税費等因素對公司盈利能力的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.